Skip to main content

Table 1 Patient characteristics and preoperative clinical factors

From: Outcomes of surgical resection for pulmonary metastasis from ovarian cancer

Pt

Age

Pathologic stage of ovarian cancer

Pathology

Treatment mode for the primary tumor

Metastatic site other than lung before pulmonary resection

Disease-free interval (months)

Laterality

Tumor number

Tumor size (mm)

FDG uptake (SUVmax)

Lymph node involvement

1

64

I

clear cell adenocarcinoma

S

none

26

unilateral

1

23

8

no

2

72

IV

serous papillary cystadenocarcinoma

S

none

188

unilateral

1

10

1.6

no

3

75

IV

serous adenocarcinoma

C + S + C

none

10

unilateral

1

17

5.9

no

4

39

III

undifferentiated carcinoma

S + C

none

31

unilateral

1

19

6.6

yes

5

44

IV

undifferentiated carcinoma

S + C

liver

0

unilateral

1

18

5.8

no

6

72

III

endometroid adenocarcinoma

S

none

18

unilateral

3

5

not done

no

  1. C chemotherapy, FDG 2-deoxy-2- [fluorine-18] fluoro-D- glucose, SUVmax maximum standardized uptake value, S surgery